This course provides an overview of the best abstracts from Gynecological Cancer:
- Phase III randomized trial of postoperative adjuvant conventional radiation (3DCRT) versus image guided intensity modulated radiotherapy (IG-IMRT) in cervical cancer (PARCER): Final Analysis
- Is the Risk of Substantial LVSI in Stage I Endometrial Cancer Similar to PORTEC in the North American Population? - A Single Institution Study
- Utilizing Immune Profiles to Predict Pelvic Failure in Endometrial Cancer
- Elective inguinal node irradiation is not necessary in cervical cancer invading lower third of vagina
- Hyperthermia Combined with Concurrent Radiochemotherapy for 373 Patients with Cervical Cancer Stage IB-IV
- Assessment of Impact of Bone Marrow Sparing for Haematological and Gastrointetstinal Toxicities in Cervical Cancer with External Beam Radiation Therapy
- Prognostic Significance of Negative Conversion of High-Risk Human Papillomavirus DNA After Treatment in Cervical Cancer Patients
The course is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, learners should be able to do the following:
- Demonstrate an increased knowledge and skills in cervical cancer radiation treatment.
- Apply new strategies in gynecologic malignancies.
- Identify which patients are eligible for treatment biomarkers in cervical cancer.
Jyoti Mayadev, MD is employed by University of California and receives compensation/remuneration/funding from Varian Medical Systems and AstraZeneca.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.